First Horizon Corp Editas Medicine, Inc. Transaction History
First Horizon Corp
- $2.11 Billion
- Q3 2025
Shares
3 transactions
Others Institutions Holding EDIT
# of Institutions
214Shares Held
45.4MCall Options Held
476KPut Options Held
338K-
Black Rock Inc. New York, NY7.78MShares$32.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$29.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.96MShares$8.13 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$7.77 Million0.0% of portfolio
-
State Street Corp Boston, MA1.85MShares$7.65 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $285M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...